[
  {
    "ts": null,
    "headline": "National Donor Day Spotlight: DaVita Patient Care Technician Donates Kidney",
    "summary": "NORTHAMPTON, MA / ACCESS Newswire / February 13, 2026 /DaVita When Holly's husband, Heston, was diagnosed with end-stage kidney disease, their lives changed overnight - bringing months of uncertainty. Driven to make a meaningful impact, Holly left ...",
    "url": "https://finnhub.io/api/news?id=7b3c732d1a68b4505405fc4f55e48513c87df3d5632386b9d7c39c03458a1692",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771009200,
      "headline": "National Donor Day Spotlight: DaVita Patient Care Technician Donates Kidney",
      "id": 139088211,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "NORTHAMPTON, MA / ACCESS Newswire / February 13, 2026 /DaVita When Holly's husband, Heston, was diagnosed with end-stage kidney disease, their lives changed overnight - bringing months of uncertainty. Driven to make a meaningful impact, Holly left ...",
      "url": "https://finnhub.io/api/news?id=7b3c732d1a68b4505405fc4f55e48513c87df3d5632386b9d7c39c03458a1692"
    }
  },
  {
    "ts": null,
    "headline": "PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up",
    "summary": "PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.",
    "url": "https://finnhub.io/api/news?id=cc589f9ba246767afe1ca5362d40d2439620d50bc0f654018984640b89924a94",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770996240,
      "headline": "PacBio Q4 Earnings and Revenues Beat Estimates, Gross Margin Up",
      "id": 139086738,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "PACB beats Q4 estimates as revenue jumps 14%, gross margin hits 41% and 2026 revenues are projected in the range of $165-$180M after strategic moves.",
      "url": "https://finnhub.io/api/news?id=cc589f9ba246767afe1ca5362d40d2439620d50bc0f654018984640b89924a94"
    }
  },
  {
    "ts": null,
    "headline": "DaVita Kidney Care Profit Milestone Highlights Emerging Value Based Earnings Mix",
    "summary": "DaVita (NYSE:DVA) reports its Integrated Kidney Care segment has reached profitability for the first time. The milestone follows a shift toward value-based contracts, digital tools and home-based kidney care services. The company links the progress to its integrated care model and clearer regulatory frameworks around kidney care delivery. For investors, the key angle is that DaVita is more than a center-based dialysis operator. The Integrated Kidney Care unit is built around coordinated...",
    "url": "https://finnhub.io/api/news?id=bf3bf3781f61a5d95a703566f562061613b01248c74832fb6ea2dbaa25ff7d97",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770959490,
      "headline": "DaVita Kidney Care Profit Milestone Highlights Emerging Value Based Earnings Mix",
      "id": 139078182,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "DaVita (NYSE:DVA) reports its Integrated Kidney Care segment has reached profitability for the first time. The milestone follows a shift toward value-based contracts, digital tools and home-based kidney care services. The company links the progress to its integrated care model and clearer regulatory frameworks around kidney care delivery. For investors, the key angle is that DaVita is more than a center-based dialysis operator. The Integrated Kidney Care unit is built around coordinated...",
      "url": "https://finnhub.io/api/news?id=bf3bf3781f61a5d95a703566f562061613b01248c74832fb6ea2dbaa25ff7d97"
    }
  },
  {
    "ts": null,
    "headline": "3 S&P 500 Stocks We Find Risky",
    "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
    "url": "https://finnhub.io/api/news?id=906ae4f72967f9ecf5a23e74f11bd438e570b907fcd64afaa0a1290f8854166a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770957869,
      "headline": "3 S&P 500 Stocks We Find Risky",
      "id": 139089886,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DVA",
      "source": "Yahoo",
      "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
      "url": "https://finnhub.io/api/news?id=906ae4f72967f9ecf5a23e74f11bd438e570b907fcd64afaa0a1290f8854166a"
    }
  }
]